Work

Advancing the Science and Management of Renal Cell Carcinoma: Bridging the Divide between Academic and Community Practices

Year: 2020

Type: article

Abstract: The treatment of metastatic renal cell carcinoma (mRCC) has rapidly evolved; however, the progress made in the field is heavily contingent upon timely and efficient accrual to clinical trials. While a substantial proportion of accrual occurs at tertiary care centers, community sites are playing an increasing role in patient recruitment. In this article, we discuss strategies to optimize collaborations between academic and community sites to facilitate clinical research. Further, as the role of biomarker discovery has become increasingly important in tailoring therapy, we will discuss opportunities to bridge diverse accrual sites for the purpose of translational research.

Source: Journal of Clinical Medicine

DOI: 10.3390/jcm9051508

Authors: Nicholas J. Salgia, Errol J. Philip, Mohammadbagher Ziari, Kelly Yap, Sumanta Kumar Pal

Institutions: City Of Hope National Medical Center, City of Hope, University of California, San Francisco

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,324